🔎 Trials Near Me

Home › Breast Cancer › NCT06648278

Patient Care Outreach, Navigation, Technology and Support 2.0

Recruiting

The Patient Care Outreach, Navigation, Technology and Support 2.0 Study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

For Focus groups:

* Breast cancer patients: Diagnosed with breast cancer, ages 18 or older, speaks English, Mandarin/Cantonese, or Spanish
* Navigators: any patient navigator who has provided care to underserved populations diagnosed with cancer

For Portal Implementation phase:

* Ages 18 or older
* Speaks English, Mandarin/Cantonese, Spanish,
* Has any stage breast cancer
* Has access to a phone that is able to receive text messages, is willing to stay in the study for six-seven months.

Family User experience survey:

* Family member or friend who may have assisted breast cancer participant with registration, accessing or otherwise assisting breast cancer family member or friend participant with the online portal.

Exclusion Criteria:

* Any medical or psychological conditions precluding informed consent

About the study

This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.

What is being tested

Sponsor: University of California, San Francisco · Participants: 260 · Started: Aug 10, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06648278

Locations in the U.S.

CaliforniaUniversity of California, San Francisco, San Francisco
Zuckerberg San Francisco General Hospital, San Francisco

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.